Impaired hepatic bile acid export may contribute to development of cholestatic druginduced liver injury dili. A 51yearold, previously healthy sri lankan man presented to our hospital with obstructive jaundice caused by a. Druginduced liver injury dili accounts for 20% between different ethnic groups and geographic locations, with highest incidence rates. Bile acids are key signaling molecules, but they can exert toxic responses when they accumulate in hepatocytes. Adaptation to injurious effects, with only a transient increase. Risk factors for development of cholestatic druginduced. Acute hepatitis, with or without cholestasis, is the. Cholestasis, drug, liver disease, druginduced liver disease. Drugs may cause several overlapping syndromes of cholestasis, the pathophysiological syndrome resulting from impaired bile flow.
Cholestasis represents one out of three types of drug induced liver injury dili, which comprises a major challenge in drug development. Cephalexin is a very commonly prescribed orally administered antibiotic which has many potential side effects. A 63yearold woman was referred to our department with progressive cholestasis and hyperbilirubinaemia following a course of flucloxacillin. Predicting druginduced cholestasis with the help of. Different clinical syndromes may be recognized, with variable degrees of hepatitis in. Druginduced prolonged cholestasis is defined by the persistence of jaundice for more than 6 mo or the continuance of biochemical disorders reflecting anicteric cholestasis for more than 1 yr after druginduced acute hepatitis despite the withdrawal of the causative drug and in the absence of a past history of chronic liver or. The task is further rendered difficult on biopsy, as drugs can mimic all the patterns found in primary liver disease. Adverse drug reactions are an important cause of liver injury that may require discontinuation of the offending agent, hospitalization, or even liver transplantation. Interestingly, there are only a few computational studies for the prediction of cholestasis reported in literature.
Role of multidrug resistance protein 3 in antifungal. Drug and estrogen induced cholestasis through inhibition of the hepatocellular bile salt export pump bsep of rat liver. Dili may be a direct toxic effect or an immunological reaction to either the drug or an active metabolite. Cholestasis also may result from damage to the interlobular bile ducts, which is characteristic of epping jaundice diaminodiphenylethane and the intraarterial infusion of floxuridine used in the treatment of metastatic cancer in the liver. Barr virus, 24 typhoid fever, 25 and acute q fever. Amongst these cholestatic jaundice has been infrequently reported as an adverse reaction. Molecular pathogenesis of intrahepatic cholestasis of. Most cases of cholestatic dili are mild but in rare cases. Most instances of druginduced cholestasis present as acute, transient illness, although important chronic forms also occur. Pdf cholestatic druginduced liver injury dili can be a diagnostic challenge due to a large differential diagnosis, variability in clinical.
Assessing the risk of druginduced cholestasis using. Technically, cholestasis is any condition in which substances normally secreted into bile are retained. Drugs can cause a diverse array of liver injury, which may be acute or chronic. Worsening cholestasis and possible cefuroximeinduced. We describe the first reported case of acute cholestasis due to citalopram selective serotonin reuptake inhibitor occurring in a patient who also experienced obstetric cholestasis in association with each of three pregnancies. Cholestatic liver disease has a wide variety of causes which often requires radiological examination to rule out extrahepatic and intrahepatic causes. The multidrug resistanceassociated proteins mrp 3 and 4 are postulated to be compensatory hepatic basolateral bile acid efflux transporters when biliary excretion by the bile salt export pump bsep is impaired. These reactions comprise approximately 17% of all hepatic adverse drug reactions adrs and they may be severe. Druginduced cholestasis is a risk factor in the progression of drug candidates, and poses a serious health hazard if not. Drug and estrogeninduced cholestasis through inhibition of the hepatocellular bile salt export pump bsep of rat liver.
Chapter 2 druginduced cholestasis semantic scholar. A liver biopsy, performed due to persistent liver injury, demonstrated an absence of bile ducts, which, in conjunction with the patients clinical course, was. It can, however, lead to severe itching, diarrhea, and. Bsep inhibition is a risk factor for cholestatic dili. Causes of pure bland cholestasis include oestrogens and anabolic steroids. Drug induced cholestasis and intrahepatic cholestasis of. Histological patterns in druginduced liver disease. In this study we applied a twoclass classification scheme based on knearest neighbors in order to predict cholestasis, using a set of 93 twodimensional 2d physicochemical descriptors and predictions of selected hepatic transporters inhibition bsep.
Like in fld, increasing plasma lcat in cholestatic mice was shown to lower lp. A high index of suspicion is required for the correct diagnosis. The drugs in this category that can lead to cholestasis include azathioprine, chlorozotocin, busulphan, aminoglutethimide and 5fluorouridine by infusion into the hepatic artery. Cholestatic druginduced liver injury dili is more common than hepatocellular dili among the elderly.
While drug induced cholestasis due to the inhibition of the bile salt export pump bsep is well investigated, only limited information on the interaction of drugs with multidrug resistance protein 3 mdr3 exists and its role in the pathogenesis of drug induced cholestasis is. Jacqueminnr1h4 analysis in patients with progressive familial intrahepatic cholestasis, druginduced cholestasis or intrahepatic cholestasis of pregnancy unrelated to atp8b1, abcb11 and abcb4 mutations. We report two cases of antidepressant induced cholestasis. Most cases of drug and herbalinduced cholestasis are benign, but progression to chronic liver disease, cirrhosis, and death is well described. Consequently, druginduced liver injury and cholestasis are important toxicity alerts to be considered in drug development.
This illustrates that there is an unmet need for a costeffective, conceptually simple, higherthroughput in vitro model, granting reliable prediction of the liability of new drug candidates regarding druginduced cholestasis. There is currently no way to reimburse for the absence of liver function. Drug induced cholestasis can, and usually does, interfere with the secretion of bile without causing hepatitis or liver cell death necrosis. Cholestasis is mostly defi ned by a biochemical pattern with predominant increase in alkaline phosphatase. Prior to their adverse action on hepatocytes, drugs need to be taken up into the cells. Hence, these 2 transporters are additional potential susceptibility factors for druginduced cholestasis. This is the first report in the literature of a fatality associated with a shortterm, low 1 g daily dose of drug induced pure cholestasis, an entity not previously identified with severe drug.
Our results indicate that recombinant lcat could have a wider therapeutic indication than just fld. We present a case of a patient with paradoxical worsening of jaundice caused by cefuroximeinduced cholestasis following therapeutic endoscopic retrograde cholangiopancreatography for a distal common bile duct stone. Hepatocytebased in vitro model for assessment of drug. Cefuroxime very rarely causes druginduced liver injury. Druginduced cholestasis can, and usually does, interfere with the secretion of bile without causing hepatitis or liver cell death necrosis. Despite the comprehensive laboratory, imaging and genetic investigations, no other cause for the cholestasis was. Druginduced cholestasis is a common entity, seen with numerous classes of pharmacological agents. The diagnosis of druginduced liver injury dili is a challenging problem, often confounded by incomplete clinical information and the difficulty of eliciting exposure to herbal products, overthecounter agents and toxins. Druginduced cholestasis and intrahepatic cholestasis of. Druginduced cholestasis is a risk factor in the progression of drug candidates, and poses a serious health hazard if not detected before going into a human.
These drug induced cholestatic disorders vary from asymptomatic patients with isolated elevations in alkaline phosphatase or gammaglutamyl transferase and liver histology showing only mild bile duct disarray or ductopenia, to progressive forms of the vbds. Its major influence is on the important cause of liver injury. Intrahepatic accumulation of bile acids bas represents a characteristic phenomenon associated with druginduced cholestasis. We discuss the different types of cholestasis that can be induced by medications and herbal supplements and the mechanisms of cholestasis caused by medications. Druginduced cholestasis is a common form of liver toxicity, yet currently there is no model or test to predict which drugs may induce cholestasis in patients. Druginduced liver disease pdf if you found this book helpful then please like, subscribe and share. It is generally used, however, to refer to any condition in which the flow of bile is reduced. Steroid therapy for a case of severe druginduced cholestasis. Druginduced cholestasis is frequent among the differential diagnoses in patients with cholestasis and normal hepatobiliary imaging. This form of drug induced cholestasis manifests itself histologically by pure canalicular cholestasis, typically produced by estrogen or anabolic steroids. Thus, cholestasis can occur with certain viral infections, such as hepatitis a and e, 23 epstein. Drug induced liver injury dili is a rare cause of liver.
Drug induced liver injury is an important clinical entity resulting in a considerable number of hospitalizations. Reports of inspissated casts in ductules benoxaprofen jaundice and injury to the major excretory tree 5fluorouridine after hepatic artery infusion have led to other forms of ductal cholestasis. Several forms of cholestatic liver injury can be produced by drugs, and these can present acutely or in the form of chronic liver disease. Druginduced liver injury dili is a descriptive term that encompasses any form of hepatotoxicity, whether hepatocellular, cholestasis or both. Druginduced cholestasis is an important form of acquired liver disease and is associated with significant morbidity and mortality. Prevention and treatment of drug induced liver disease. These drug induced cholestatic disorders are rare and cause minimal or no hepatic parenchymal involvement. Investigations of the genetics of dili have proved taxing, both because of their low incidence and their difficulty in replicating observed associations.
298 1483 420 789 1139 766 384 427 300 1120 803 1358 80 1461 1490 119 672 456 991 400 233 108 1314 778 768 712 17